Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer

Seminars in Cancer Biology(2021)10.1016/j.semcancer.2021.12.004Source: DataRank Database

Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer is a research paper published in Seminars in Cancer Biology (2021). On theSindex it has a DataRank of 0. It has been cited 209 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access209 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 12.91)OA: greenTopics (36)Linked Datasets (6)DataCite Reuse (6)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Ramon U. Jin ORCID,Yongji Zeng ORCID

Live enrichment

PubMed:34933124 PMC:PMC12833737 OpenAlex:https://openalex.org/W4200506756

NCI NIH HHS

Grant: U54 CA163060

NIH

US Department of Defense

ASCO

FWCI

12.91

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12833737/

publisherhttps://api.elsevier.com/content/article/PII:S1044579X21002972?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1044579X21002972?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.semcancer.2021.12.004

Fields of Study

Gastric Cancer Management and OutcomesCancer Genomics and DiagnosticsGastrointestinal Tumor Research and TreatmentMiceAnimalsHumansStomach NeoplasmsMolecular Targeted TherapyCarcinogenesisPrecision MedicineMutation

MeSH Terms

AnimalsHumansMutationStomach NeoplasmsMicePrecision MedicineMolecular Targeted TherapyCarcinogenesis

Keywords

CancerTranslational researchTargeted therapyDiseaseCancer cellBioinformaticsCancer researchMedicinePrecision medicineBiologyInternal medicinePathologyMouse ModelsPrecision OncologyCancer OrganoidsPaligenosisCyclical Hit Model

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study

10.6084/m9.figshare.25522676.v1figshare

Additional file 1 of A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study

10.6084/m9.figshare.25522676figshare

Additional file 2 of A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study

10.6084/m9.figshare.25522798.v1figshare

Additional file 2 of A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study

10.6084/m9.figshare.25522798figshare

Additional file 3 of A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study

10.6084/m9.figshare.26700469.v1figshare

Additional file 3 of A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study

10.6084/m9.figshare.26700469figshare